LES Foundation | LESI | Print Page | Contact Us | Sign In | Join
Due Diligence – Avoiding the Potholes on the Road to a Successful License
Tell a Friend About This EventTell a Friend
 

LES New York City Chapter Event

6/11/2015
When: Thursday, June 11, 2015
6:00 PM - 8:00 PM
Where: Kenyon and Kenyon
One Broadway
New York, New York  10004-1007
United States

« Go to Upcoming Event List  

DATE & TIME
Thursday, June 11, 2015
6:00 PM - 8:00 PM

LOCATION
Kenyon and Kenyon
One Broadway
New York, NY 10004-1007

TITLE
Due Diligence – Avoiding the Potholes on the Road to a Successful License

MODERATOR
Elizabeth Gardner, Partner, Kenyon & Kenyon LLP

PANELISTS
Julie Blackburn, Vice President Business Development, The Estee Lauder Companies Inc.
Kathleen Denis, PhD, Associate Vice President, Technology Transfer, The Rockefeller University
Kalpana Gupta, PhD, MBA, Director Business Development, Regeneron Pharmaceuticals, Inc.
Matthew Price, Executive Vice President, Phosplatin Therapeutics

DESCRIPTION
Licensing is an exciting (and complex) activity whether you are the Licensor or Licensee. Getting caught up in “the Deal” without proper diligence can result in a poor deal or no deal at all.

Our panel of experts will provide insights into what is necessary and what is “good to know” before you sit down at the negotiating table. Topics will include reputation (yours and theirs), intellectual property and trade secrets, competition, financial terms, termination, indemnification, ownership of rights, and other important terms and conditions of a license. Learn from our panelists about where and how to gather diligence information that can provide the knowledge that will lead to a productive negotiation and successful license.

REGISTRATION
ONLINE, by June 8, 2015
LES Member: $45
Non-Member: $60

ONSITE
LES Member: $60
Non-Member: $75

Online Registration Deadline: Monday, June 8, 12 PM EDT

CANCELLATION POLICY
No refunds after June 8
Substitutions are permitted

SPEAKER BIOS
Julie Blackburn, Vice President – Deputy General Counsel (Patents), The Estee Lauder Companies Inc.
Julie holds a law degree from Baylor University. Her 30+ years of experience in the legal/patent field have been in the Beauty industry. Prior to joining The Estee Lauder Companies she spent 17 years as Senior Patent Counsel & Assistant Secretary at Revlon Consumer Products Corporation. Her practice areas include technology based transactions, patent procurement, licensing, legal opinions, and supporting and executing on business strategy.

Kathleen Denis, PhD, Associate Vice President, Technology Transfer, The Rockefeller University
Kathleen A. Denis, PhD, CLP is the Associate Vice President of Technology Transfer at The Rockefeller University, a premier biomedical research institution located in New York City. She is a Past President of the Licensing Executives Society USA/Canada (LES), and has served on the Board of Directors of the Association of University Technology Managers (AUTM) and the Pennsylvania Biotechnology Association. She is a Certified Licensing Professional, a Registered Technology Transfer Professional, and the former Chair of the Board of Governors of Certified Licensing Professionals, Inc.

Specializing in the management of intellectual assets in the life sciences, she has worked with academic institutions and industry clients to manage intellectual property portfolios, evaluate new technologies, market and license technologies and start new technology-based businesses. Dr. Denis is active in numerous professional organizations and speaks frequently about early stage technology evaluation, formation of start-up companies, conflict of interest and other issues of academic technology transfer.

Dr. Denis holds a Ph.D. in immunology from the University of Pennsylvania, an M.A. in Human Genetics from University of Texas Medical Branch at Galveston and an undergraduate degree in genetics from Cornell University.

Elizabeth Gardner, Partner, Kenyon & Kenyon LLP
Elizabeth Gardner is a partner at the New York Office of Kenyon & Kenyon LLP . She handles a variety of patent-related matters including litigation, client counseling, the negotiation and drafting of technology transfer agreements, license agreements, joint development agreements, as well as the prosecution of patents before the United States Patent and Trademark Office. For over 20 years, she has focused her practice on all phases of litigation involving patented and trade secret protected technology. She has represented clients in a broad range of technology areas, including in the chemical, materials, pharmaceutical, electrical, medical products, and medical diagnostics industries. She has represented clients in numerous bench trials, jury trials, pre-trial proceedings in both Federal district courts, the International Trade Commission, and in appeals before the U.S. Court of Appeals for the Federal Circuit. She has also represented clients in patent office proceedings including inter partes reviews (IPR), reexaminations, and interferences.

Kalpana Gupta PhD, MBA, Director Business Development, Regeneron Pharmaceuticals, Inc.
Kalpana Gupta joined the Strategy and Business Development team at Regeneron Pharmaceuticals in May 2014.  Kalpana has extensive experience in the life sciences industry and in the non-profit sector in drug & technology development. Prior to Regeneron, she was with PwC’s Healthcare and Life Sciences Advisory Practice.  Up until 2012 Kalpana was Director New Alliances and Strategic Initiatives at the International AIDS Vaccine Initiative where she led the organization’s external R&D / innovation function.  Kalpana received her doctoral degree from the Johns Hopkins University School of Medicine and is a graduate of Columbia University’s Executive MBA program.

Matthew R. Price, Executive Vice President, Phosplatin Therapeutics
Matthew Price was a co-founder of Phosplatin Therapeutics, and is responsible for strategy, finance and operations across the seven countries in which the company has been active. His role includes overall management of the company’s patent estate and negotiations related to in- and out-licensing. He holds an A.B. from Princeton University, where he graduated summa cum laude and Phi Beta Kappa, and a masters degree from the University of the Arts Berlin. He earned an MBA with distinction from Columbia Business School in 2009, where he focused on private equity and entrepreneurship and was a Chazen Society Fellow in International Business.